- Zacks•16 hours ago
Celgene (CELG) reported better-than-expected third-quarter 2016 earnings and revenues; it once again raised the earnings outlook for 2016.
- Zacks•17 hours ago
The Medicines Company (MDCO) reported a loss of 75 cents per share in the third quarter of 2016, significantly narrower than both the Zacks Consensus Estimate of a loss of $1.38 and the year-ago loss of 94 cents.
- Zacks•2 days agoZacks.com featured highlights: Incyte, LegacyTexas Financial Group, Exelixis, Bayerische Motoren Werke Aktiengesellschaft and EQT Midstream Partners
Zacks.com featured highlights: Incyte, LegacyTexas Financial Group, Exelixis, Bayerische Motoren Werke Aktiengesellschaft and EQT Midstream Partners
Exelixis, Inc. (EXEL)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
|Day's Range||10.83 - 11.37|
|52wk Range||3.55 - 15.58|
|1y Target Est||N/A|
Trade prices are not sourced from all markets
|P/E Ratio (ttm)||-13.00|
|Avg Vol (3m)||6,500,595|
|Dividend & Yield||N/A (N/A)|